Dyspnea Management in Early-Stage Lung Cancer

Williams, Anna; Grant, Marcia; Tiep, Brian; Kim, Jae Y.; Hayter, J

doi:10.1097/njh.0b013e31825e4250

Cited by 7 publications

(4 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with lung cancer and COPD benefit from a multidisciplinary disease management approach throughout their illnesses to ensure maximum QOL and functional status (for themselves and their families). In collaboration with a pulmonologist, oncology and advanced practice nurses can help improve these patients’ health outcomes using pharmacologic and nonpharmacologic treatments and symptom management (Shinde & Dashti, 2016; Williams, Grant, Tiep, Kim, & Hayter, 2012). More clinical research is needed to expand understanding of the management of patients with this twofold disease burden, to increase the use of existing evidence-based interventions, and to develop and test new QOL-boosting interventions.…”

Section: Resultsmentioning

confidence: 99%

Chronic Obstructive Pulmonary Disease: Clinical Implications for Patients With Lung Cancer

Newsome

McDonnell

Hucks

et al. 2018

CJON

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Chronic Obstructive Pulmonary Disease: Clinical Implications for Patients With Lung Cancer

Newsome

McDonnell

Hucks

et al. 2018

CJON

View full text Add to dashboard Cite

show abstract

“…Consequently, patients feel discouraged or hopeless, which differs from dyspnea in patients with other respiratory diseases. As per the literature review [6,7], dyspnea more frequently occurs in patients with lung cancer than in patients with other types of cancer. Furthermore, studies in Thailand have found patients with lung cancer undergoing chemotherapy have dyspnea at a rate as high as 76.1% [8].…”

Section: Introductionmentioning

confidence: 91%

The Effects of the Respiratory Rehabilitation Program on Perceived Self-Efficacy and Dyspnea in Patients with Lung Cancer

Saetan

Chaiviboontham

Pokpalagon

et al. 2020

Asian Nursing Research

View full text Add to dashboard Cite

This study aims to examine the effects of the respiratory rehabilitation program on perceived self-efficacy and dyspnea in patients with lung cancer. Methods: This is a quasi-experimental research study with a two-group repeated measures design with the pretest and post-test at Week 4 and Week 8. The theory of self-efficacy by Bandura was used as the conceptual framework. The sample consisted of patients with nonesmall-cell lung cancer Stage 4 who visited the oncology clinic in a university hospital. Twenty-eight patients were enrolled and equally allocated to the control group and experimental group. The control group received routine nursing care only, whereas the experimental group received the respiratory rehabilitation program. The program comprised dyspnea educating, breathing exercise, using handheld fans, effective coughing, respiratory strengthening training, and follow-up by phone in the third and sixth week. Data for perceived selfefficacy and dyspnea were collected before the program start and reassessment in the fourth and eighth week. Instrumentation was composed of the respiratory rehabilitation program, demographic data, perceived self-efficacy assessment for respiratory rehabilitation, and the Cancer Dyspnea Scale. Data were analyzed using descriptive statistics and one-factor repeated measures analysis of variance and by comparing means between groups. Results: The result revealed that almost all of the patients in the sample were men, and the mean age of the experimental group and control group was 65.80 years (standard deviation ¼ 8.80) and 73.00 years (standard deviation ¼ 7.60), respectively. There was significant different in the mean score of perceived self-efficacy and dyspnea between the experimental group and the control group (p < .050). Conclusion:Based on the findings of the study, the respiratory rehabilitation program should be used to promote self-efficacy and relieve dyspnea in patients with lung cancer.

show abstract

“…According to the American Thoracic Society, estimates range from 55% to 87% of all patients with lung cancer experiencing chronic breathlessness, i.e., dyspnea (Shin et al, 2014;Williams, Grant, Tiep, Kim, & Hayter, 2012). Additionally, almost all patients with lung cancer report a persistent cough and functional limitations (O'Mahony et al, 2016).…”

Section: Introductionmentioning

confidence: 99%

“…Breathlessness, often referred to as the sixth vital sign (Williams et al, 2012), is a distressing sensation that can involve anxiety and even panic, which results in cycling, a worsening of the breathlessness and anxiety. Hence, there is a critical need to understand the role of anxiety in worsening breathlessness and to test strategies which may reduce the sensations of breathing insufficiency and the accompanying anxiety.…”

Section: Introductionmentioning

confidence: 99%

Improving biobehavioral outcomes with progressive muscle relaxation in patients with advanced lung cancer.

Arrato

Grogan

et al. 2019

JCO

View full text Add to dashboard Cite

292 Background: Advanced lung cancer involves severe and distressing symptoms, especially anxiety, breathlessness, insomnia, and pain. Progressive muscle relaxation (PMR) is an empirically supported treatment for reducing stress and the emotional, cognitive, and physiological concomitants of anxiety. Methods: A quality improvement effort involved enhancing standard of care (SOC) by offering patients with newly diagnosed lung cancer one brief (20-minute) PMR session during a clinic visit for treatment determination. A static group comparison design was used. The PMR group ( n= 40) received PMR with pre (initial visit) and post (3-4 week follow-up) assessments of anxiety (Generalized Anxiety Disorder-7 Scale), breathlessness (American Thoracic Society for the Division of Lung Diseases Questionnaire), insomnia (Medical Outcomes Study Sleep Scale), and pain (Brief Pain Inventory). The static group ( n= 32) was assessed on one occasion only, during the 3-4 week follow-up visit. Pre/post analyses for the PMR group used paired samples t-tests. Linear regressions compared post data between the two groups. An alpha of .10 determined significance. Results: Analyses showed pre- to post-PMR differences in pain ( p= .036, d= .309) and breathlessness ( p= .084, d= .663), with null effects for anxiety ( p= .149, d= .178) and insomnia ( p= .811, d= .067). Controlling for performance status, smoking history, and toxicities, regression showed that the PMR group reported significantly less pain ( p= .046, b= 2.48). Conclusions: PMR effectively reduced symptoms of breathlessness and pain among patients with advanced lung cancer. Interventions based on the education and training of PMR may provide an improvement to SOC lung cancer treatment.

show abstract

Dyspnea Management in Early-Stage Lung Cancer

Cited by 7 publications

References 23 publications

Chronic Obstructive Pulmonary Disease: Clinical Implications for Patients With Lung Cancer

Chronic Obstructive Pulmonary Disease: Clinical Implications for Patients With Lung Cancer

The Effects of the Respiratory Rehabilitation Program on Perceived Self-Efficacy and Dyspnea in Patients with Lung Cancer

Improving biobehavioral outcomes with progressive muscle relaxation in patients with advanced lung cancer.

Contact Info

Product

Resources

About